TABLE 2.
Participants’ characteristics and DXA parameters at baseline (See Supplementary Material S3) and (Fardellone et al., 1991) for Fardellone self-questionnaire. (See Supplementary Material S1) for lifetime activity questionnaire (QUANTAP). QUANTAP total lifetime activity and current level of physical activity at recruitment were reported in Kilojoules/Kilograms (Kj/Kg).
| Group | |||||
|---|---|---|---|---|---|
| Control (n = 98) | Vibration (n = 99) | p-value | |||
| Mean | SD | Mean | SD | ||
| Participants’ baseline characteristics | |||||
| Age | 66.1 | 5.39 | 63.27 | 4.94 | < 0.001 |
| (MOF) Frax score | 6.04 | 2.63 | 5.41 | 2.09 | 0.062 |
| (Fardelonne) daily calcium intake (mg) | 762.24 | 383.92 | 677.9 | 323.02 | 0.099 |
| (QUANTAP) total lifetime activity at recruitment (Kj/kg) | 108,8338.88 | 625,610.81 | 112,2443.84 | 579,877.59 | 0.698 |
| (QUANTAP) current physical activity levels at recruitment (Kj/kg) | 22,965.06 | 16,743.94 | 24,198.09 | 15,973.68 | 0.607 |
| Calcium (mmol/L) | 2.29 | 0.25 | 2.28 | 0.08 | 0.739 |
| Phosphate (mmol/L) | 1.21 | 0.19 | 1.21 | 0.18 | 0.983 |
| 25-OH Vitamin D (µg) | 27.04 | 10.91 | 29.73 | 9.82 | 0.07 |
| Parathyroid hormone (ng/L) | 29.94 | 11.35 | 29.77 | 10.44 | 0.911 |
| Height (cm) | 159.33 | 5.82 | 158.12 | 5.43 | 0.133 |
| Body mass (kg) | 66.8 | 13.15 | 63.5 | 10.71 | 0.058 |
| BMI (kg/m2) | 26.21 | 4.84 | 25.11 | 4.14 | 0.089 |
| DXA and 3D- Shaper | |||||
| Total BMD (g/cm2) | 1.02 | 0.09 | 1.01 | 0.1 | 0.371 |
| Total T-score (SD) | 0.05 | 0.93 | −0.08 | 0.98 | 0.371 |
| Fat mass (g) | 26,845.52 | 9,543.16 | 24,673.83 | 7,314.66 | 0.074 |
| Lean mass (g) | 37,858.96 | 4,363.89 | 36,812.57 | 4,169.27 | 0.087 |
| Body mass (g) | 66,806 | 13,157.84 | 63,545.19 | 10,713.35 | 0.058 |
| BMD spine L1-L4 (g/cm2) | 1.06 | 0.16 | 1.04 | 0.15 | 0.398 |
| T-score spine L1-L4 (SD) | −0.86 | 1.35 | −1.01 | 1.21 | 0.398 |
| Trabecular bone score L1-L4 (g/cm2) | 1.26 | 0.09 | 1.28 | 0.1 | 0.162 |
| BMD femoral neck (g/cm2) | 0.85 | 0.09 | 0.84 | 0.09 | 0.253 |
| T-score femoral neck (SD) | −1.07 | 0.73 | −1.2 | 0.79 | 0.253 |
| BMD Total Hip (g/cm2) | 0.89 | 0.1 | 0.87 | 0.11 | 0.071 |
| T-score total hip (SD) | −0.88 | 0.85 | −1.11 | 0.88 | 0.071 |
| 3D-Shaper total cortical vBMD (mg/cm3) | 803.9 | 84.05 | 788.19 | 84.62 | 0.193 |
| 3D-Shaper total trabecular vBMD (mg/cm3) | 140.42 | 33.09 | 135.05 | 35.21 | 0.272 |
| 3D-Shaper cortical vBMD of the neck (mg/cm3) | 803.7 | 74.97 | 786.53 | 74.77 | 0.109 |
| 3D-Shaper trabecular vBMD of the neck (mg/cm3) | 187.91 | 37.06 | 185.99 | 37.51 | 0.719 |